Clinical Trial Update: Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial is evaluating apatinib in combination with platinum-based doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)

Snippet

Sponsor: West China Hospital | Conditions: Lung Cancer, Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN